BFM
WST icon

Boothbay Fund Management’s West Pharmaceutical WST Stock Holding History

Boothbay Fund Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$802K Buy
+3,200
New +$796K 0.01% 1067

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management's WST Position: Q1 2026 in Review

Boothbay Fund Management reduced its West Pharmaceutical (WST) stake by 23% in Q1 2026, selling an estimated $139K and leaving 1,855 shares worth $465K. The position accounts for 0.01% of the portfolio, ranked #1393.

Boothbay Fund Management first reported a position in WST in Q2 2021 and has held it in 9 quarters since. The position peaked at $1.73M in Q1 2023. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Boothbay Fund Management held 1,855 shares of West Pharmaceutical worth $465K as of Q1 2026.
  • Boothbay Fund Management sold 558 West Pharmaceutical shares in Q1 2026, an estimated $139K.
  • West Pharmaceutical made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1393 holding.
  • Boothbay Fund Management first reported a position in West Pharmaceutical in Q2 2021 and has held it in 9 quarters since.
  • Boothbay Fund Management's West Pharmaceutical position peaked at $1.73M in Q1 2023.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.